Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study - Wikidata - awgldk - TriplyDB

Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study

Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study

http://www.wikidata.org/entity/Q33714119

about

Primary central nervous system lymphoma

P2860

Q57297768-CC94F939-5267-41CF-9AC1-B352AD40E456

P2860

Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study

http://www.wikidata.org/entity/Q33714119

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Efficacy and safety of pemetre ...... in China: a prospective study

@ast

Efficacy and safety of pemetre ...... in China: a prospective study

@en

type

label

Efficacy and safety of pemetre ...... in China: a prospective study

@ast

Efficacy and safety of pemetre ...... in China: a prospective study

@en

prefLabel

Efficacy and safety of pemetre ...... in China: a prospective study

@ast

Efficacy and safety of pemetre ...... in China: a prospective study

@en

P1433

Q33714119-7F618F2A-3C6F-4B90-8903-D16A89B03211

P1476

Q33714119-E118D7B9-AEC6-44A0-B8CB-1C0B97C2E07F

P2093

Q33714119-1117B528-6931-4804-AC63-FDD11F69C9C4

Q33714119-176E06C4-2E40-46A5-B9A4-1E20F68F7359

Q33714119-1D38085F-A9D8-4D2A-8BE3-6207EC5DCCF8

Q33714119-24B89735-5199-4C76-B9C0-5AA2DCBCE0B7

Q33714119-4E12597E-DC70-4728-8C68-6E6F4CF4BC92

Q33714119-5BFFA873-DE89-408A-B6C2-70261BFA8510

Q33714119-75BE9AF6-7670-452A-82F5-AA291A467B7E

Q33714119-76DA9B4B-752C-4FD8-9518-490F9A95480A

Q33714119-8D3F4BD0-7398-4538-AE6D-61076D8408A6

Q33714119-A27A8837-0659-449C-8437-4F66EF4A1EC1

P2860

Q33714119-0BF0DA9C-D29C-40B6-B33C-FB30D01023CC

Q33714119-2588B1FB-924B-40DF-BE05-18194E9ECEA1

Q33714119-3CA49EFD-F61F-4554-8DAF-0A87B438044B

Q33714119-5219A625-08C0-484C-86CA-CD4A0FA0B452

Q33714119-65FD448F-79E8-499E-9F93-811DC2233234

Q33714119-6B70E040-D898-419C-839B-8F5299CF6177

Q33714119-74CC9753-4D4A-4227-8F45-2587BAA14C4D

Q33714119-AB188E7D-3AB9-474C-9DBD-1F358A20240C

Q33714119-B1A02807-D59D-436C-91A8-BFC6E7663D05

Q33714119-B663F62F-E3AF-491C-B030-0B54E5DA777E

P304

Q33714119-4663C963-D37B-40DC-BFF0-6045C4E788D1

P31

Q33714119-A7EF8AC0-E9BB-44F0-9D4C-AA7F91872D3E

P356

Q33714119-3073F7B3-6B25-4279-AFB5-DFB01BDDB48D

P407

Q33714119-97813DA6-1AD6-4622-9042-0ED1D8BCB7BC

P478

Q33714119-6975065F-CE08-4481-9F5A-96B90338B89A

P577

Q33714119-456FB77C-C831-47ED-A123-A4CE6EDB073B

P698

Q33714119-1A6DC912-4330-40C4-929A-B9AA9D0CF5E3

P932

Q33714119-827645F1-734F-400C-AB03-6786F0AF50DC

P356

P1433

OncoTargets and Therapy

P1476

Efficacy and safety of pemetre ...... in China: a prospective study

@en

P2093

Bo Xing

http://www.w3.org/2001/XMLSchema#string

Hong Li

http://www.w3.org/2001/XMLSchema#string

Jun Xu

http://www.w3.org/2001/XMLSchema#string

Rongjie Tao

http://www.w3.org/2001/XMLSchema#string

Shaolong Han

http://www.w3.org/2001/XMLSchema#string

Shizhen Zhou

http://www.w3.org/2001/XMLSchema#string

Xiuhua Wang

http://www.w3.org/2001/XMLSchema#string

Yi Sun

http://www.w3.org/2001/XMLSchema#string

Yong Wang

http://www.w3.org/2001/XMLSchema#string

Yufang Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma.

Pemetrexed in head and neck cancer: a systematic review.

Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

Temozolomide as salvage treatment in primary brain lymphomas.

Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.

Diagnosis and treatment of primary CNS lymphoma.

Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma.

A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide.

Rituximab significantly improves complete response rate in patients with primary CNS lymphoma.

P304

2595-2600

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S134684

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28553124

http://www.w3.org/2001/XMLSchema#string

P932

5440074

http://www.w3.org/2001/XMLSchema#string